Bulgarian pharmaceutical sector under antitrust scrutiny, watchdog says
MLex Summary: Bulgaria's wholesale and retail pharmaceutical markets will be the focus of a new sector inquiry, the country’s antitrust authority said today. The analysis will examine the structure and conditions...To view the full article, register now.
Already a subscriber? Click here to view full article